AOD9604 (hGH 176-191 Fragment)
The lipolytic hGH fragment researchers isolate for β-adrenergic work.
Drag the vial to rotate the label
This compound is not currently available for purchase. Submit a request to help guide future inventory and testing priorities.
The lipolytic hGH fragment researchers isolate for β-adrenergic work.
AOD9604 is a modified 16-amino-acid fragment corresponding to the C-terminal region (176–191) of human growth hormone, with an added N-terminal tyrosine. Unlike full-length hGH, it retains the fragment's lipolytic activity without the growth-promoting or insulin-antagonist properties, making it a common tool compound in cultured adipocyte lipolysis, fatty-acid oxidation, and β3-adrenergic pathway studies. Supplied as a sterile lyophilized powder. Research use only.
- Lipolytic pathway assays
- β3-adrenergic receptor interaction studies
- Independently verified for identity and purity on a batch-specific basis.
- Certificates of analysis publicly accessible by lot ID — never averaged.
- Sourced through qualified manufacturing partners and shipped from the United States.
- Fast shipping, always tracked, shipped from the United States.
Research and documentation
Where this lot is in the release process
- 01
Backorder confirmed
Your product is reserved from the incoming lot.
- 02
Arriving for testing · ~6 days
Incoming lot is expected to reach our testing queue within 6 days.
- 03
Sample en route to lab
A representative sample is being sent for independent analytical testing.
- 04
Independent testing · 3–5 days
Identity, purity, and applicable analytical testing are completed.
- 05
Results verified
Results are reviewed and the certificate of analysis is published.
- 06
Ready to ship
Verified inventory is released and your order is prepared for shipment.
Timeframes are estimates. No certificate from another lot is substituted while testing is in progress.
